$CLS · CELESTICA INC
Celestica filed an 8-K with its Investor and Analyst Day presentation, disclosing Q3 2026 financials alongside FY2023-FY2025 historicals. Q3 2026 GAAP earnings from operations hit $460.0M (annualized $1.84B), while non-GAAP adjusted EBIAT reached $496.1M (annualized $1.98B). Non-GAAP adjusted ROIC surged to 64.7%, up from 37.1% in FY2025. Total assets stood at $15.14B with $3.96B in cash as of Q3 2026 end.
- Q3 2026 GAAP earnings from operations: $460.0M, annualized to $1.84B — nearly double FY2025's $1.04B.
- Non-GAAP adjusted EBIAT for Q3 2026 reached $496.1M, annualizing to $1.98B vs $927.0M in FY2025.
- Non-GAAP adjusted ROIC hit 64.7% in Q3 2026, up from 37.1% in FY2025 and 27.2% in FY2024.
- Total assets ballooned to $15.14B at Q3 2026 end from $7.21B at FY2025 end, driven by $3.96B cash.
- YTD 2026 GAAP earnings from operations: $1.19B already exceeds full-year FY2025's $1.04B.
Extended-hours trading shows CLS at $283.33, +14.99% above the regular-session close of $246.40, indicating strong positive reaction to the Investor Day presentation and Q3 metrics.
Celestica's Q3 annualized operating profit doubling year-over-year and ROIC reaching 64.7% signals extraordinary operating leverage from AI-driven demand.
Celestica's 64.7% non-GAAP adjusted ROIC and accelerating margin expansion place it among the top-performing EMS/contract manufacturing peers, reflecting AI infrastructure demand tailwinds.
Rapid asset growth to $15.14B and cash accumulation to $3.96B may signal acquisition-related integration risk or capital allocation uncertainty. TRS FVAs swung from a $253M benefit in FY2025 to undisclosed levels in 2026.